← Leaderboards
Delbert G Robinson
Long Island Jewish Medical Center
$11,665,634
Attributed
$15,727,420
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,386,988 · 17
By mechanism
R01$10,706,766 · 2
P01$2,930,417 · 3
M01$1,793,461 · 8
P30$838,809 · 2
R34$654,160 · 1
R21$463,375 · 1
Top collaborators
- John M Kane6 shared
- Philip R Szeszko2 shared
Most similar at Long Island Jewish Medical Center
Same institution · by research overlap
- John M Kane$49,583,682
- Anil K Malhotra$14,850,627
- Michael T. Borenstein$525,636
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaPharmaceutical PreparationsAntipsychotic AgentsTreatment OutcomeResearch PersonnelPreventMedication ComplianceFirst Episode SchizophreniaFamilyReportingGrantHealth SystemFundingServicesTrainingAdverse EffectsBaseMorbidity - Disease RateLearningSymptomsResponseProgramsDesignPsychotic Disorders
Grant awards (36)
Early-Phase Psychosis: Practice-Based Research to Improve Treatment Outcomes$1,659,568
P01 · FY2025 · MH · contact PI
Early-Phase Psychosis: Practice-Based Research to Improve Treatment Outcomes-Administrative Core$1,014,342
P01 · FY2025 · MH · contact PI
Clinical Practice Data Research Project: Enhancing Patient Engagement in LHS Participant and in CSC Treatment$256,507
P01 · FY2025 · MH · contact PI
Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)$1,483,303
R01 · FY2023 · MH · contact PI
Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)$1,480,860
R01 · FY2022 · MH · contact PI
Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)$1,485,095
R01 · FY2021 · MH · contact PI
Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)$1,504,444
R01 · FY2020 · MH · contact PI
Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)$1,620,699
R01 · FY2019 · MH · contact PI
Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)$85,796
R01 · FY2019 · MH · contact PI
Detecting Which Patients With Schizophrenia Will Improve With Omega 3 Treatment$210,625
R21 · FY2014 · MH · contact PI
Adherence Unit (Research Methods Core)$60,096
P30 · FY2014 · MH · contact PI
Detecting Which Patients With Schizophrenia Will Improve With Omega 3 Treatment$252,750
R21 · FY2013 · MH · contact PI
Adherence Unit (Research Methods Core)$61,230
P30 · FY2013 · MH · contact PI
Adherence Unit (Research Methods Core)$58,536
P30 · FY2012 · MH · contact PI
Adherence Unit (Research Methods Core)$18,320
P30 · FY2012 · MH · contact PI
Adherence Unit (Research Methods Core)$57,802
P30 · FY2011 · MH · contact PI
CLINICAL TRIAL: PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$676,250
M01 · FY2010 · RR · contact PI
Adherence Unit (Research Methods Core)$57,189
P30 · FY2010 · MH · contact PI
CLINICAL TRIAL: PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$265,357
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$660,253
M01 · FY2008 · RR · contact PI
Preventing Morbidity in First Episode Schizophrenia$537,278
R01 · FY2008 · MH · contact PI
2-Way Pagers to Improve Schizophrenia Medication Adherence$216,290
R34 · FY2008 · MH · contact PI
CLINICAL TRIAL: PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$2,762
M01 · FY2008 · RR · contact PI
Preventing Morbidity in First Episode Schizophrenia$547,666
R01 · FY2007 · MH · contact PI
2-Way Pagers to Improve Schizophrenia Medication Adherence$216,290
R34 · FY2007 · MH · contact PI
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$120,151
M01 · FY2007 · RR · contact PI
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$14,651
M01 · FY2007 · RR · contact PI
Preventing Morbidity in First Episode Schizophrenia$550,974
R01 · FY2006 · MH · contact PI
2-Way Pagers--Improve Schizophrenia Medication Adherence$221,580
R34 · FY2006 · MH · contact PI
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$41,686
M01 · FY2006 · RR · contact PI
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$12,351
M01 · FY2006 · RR · contact PI
Preventing Morbidity in First Episode Schizophrenia$616,772
R01 · FY2005 · MH
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$793,879
R01 · FY2002 · MH
CORE--CLINICAL ASSESSMENT AND TRAINING$175,212
P30 · FY2002 · MH
CORE--CLINICAL ASSESSMENT AND TRAINING$175,212
P30 · FY2001 · MH
CORE--CLINICAL ASSESSMENT AND TRAINING$175,212
P30 · FY2000 · MH